Clinical trial
Repeat Doses Of A New Medication (GW642444) In Asthmatic Patients
NCT00347139 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00347139 |
|---|---|
| Title | Repeat Doses Of A New Medication (GW642444) In Asthmatic Patients |
| Official title | Multi-centre, Randomised, Double-blind, Placebo-controlled, Four-way Incomplete Block Crossover Study, to Examine Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Single and Repeat Administration of Three Inhaled Doses (25, 100 and 400 mcg Once Daily) of GW642444 |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive |
| Intervention type | Drug |
| Interventions | GW642444 (25, 100 & 400 mcg/day), Salmeterol 50mcg |
| Enrollment | 55 |
| Start date | May 23, 2006 |
| Primary completion | Jan 10, 2007 |
| Completion | Jan 10, 2007 |
| First posted | Jul 4, 2006 |
| Last update posted | Sep 14, 2017 |
| Countries | Germany, New Zealand, Russia, Sweden, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: